University of Cologne Jul 10 2025 Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their own children after treatment. An international study led by the German Hodgkin Study Group (GHSG) at University Hospital Cologne and the University's Faculty of Medicine has shown: The new BrECADD chemotherapy regimen preserves fertility significantly better than the previous standard eBEACOPP – without worsening the chances of recovery.